Related Experiment Videos
Clinical reversal of multidrug resistance
B I Sikic1, G A Fisher, B L Lum
1Stanford University Medical Center, CA 94305.
Cancer Treatment and Research
|January 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Should Therapeutic Drug Monitoring for Monoclonal Antibodies Remain the Exception or Become the Norm?
Clinical pharmacology and therapeutics·2016
Subcutaneous versus intravenous formulation of trastuzumab for HER2-positive early breast cancer: updated results from the phase III HannaH study.
Annals of oncology : official journal of the European Society for Medical Oncology·2014
A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib.
Annals of oncology : official journal of the European Society for Medical Oncology·2013
Determination of GDC-0449, a small-molecule inhibitor of the Hedgehog signaling pathway, in human plasma by solid phase extraction-liquid chromatographic-tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2010
Clinical Trials and Translational Advances in Metabolic Targeting.
Cancer treatment and research·2026
Tools and Technologies for Studying Cancer Metabolism.
Cancer treatment and research·2026
Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.
Cancer treatment and research·2026
Biomarkers of Cancer Metabolism and Therapeutic Response.
Cancer treatment and research·2026
Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.
Cancer treatment and research·2026
Metabolic Reprogramming in Cancer Stem Cells.
Cancer treatment and research·2026
Deficiency of GLUT1 in macrophages reprograms tumor-associated macrophages to normalize tumor vasculature and retards the progression of tumors.
International journal of biological sciences·2026
From static risk to dynamic disease monitoring: the role of MRD and immune profiling in multiple myeloma.
Frontiers in immunology·2026
Doravirine and islatravir for HIV-1 treatment: A systematic review and meta-analysis with GRADE assessment.
Therapeutic advances in infectious disease·2026
Advancement in Inflammation-responsive Drug Delivery System for Chronic Inflammation.
Anti-inflammatory & anti-allergy agents in medicinal chemistry·2026